 Importance dose lymphoblastic leukaemia possibility total dosage 'maintenance treatment recent improvement outlook children United Kingdom lymphoblastic leukaemia details amount prescribed first years treatment unselected cohort children Eighty patients group improvement relapse free survival years median total dose protocol average boys girls dose reductions myelosuppression findings clinical impression important therapeutic difference new United Kingdom acute lymphoblastic leukaemia protocols increase amount children result changes guidelines evidence tolerate girls unexplained difference prognosis sexes